Actualités TC BioPharm Holdings PLC - TCBP | Actions NASDAQ

TCBP Announces H5N1 Proof of Concept Studies Intention

TCBP Announces H5N1 Proof of Concept Studies Intention PR Newswire EDINBURGH, Scotland, Jan. 15, 2025...

TCBP to Present at Sequire Investor Summit 2025

TCBP to Present at Sequire Investor Summit 2025 PR Newswire EDINBURGH, Scotland, Jan. 13, 2025 EDINBURGH...

/C O R R E C T I O N -- TC BioPharm/

/C O R R E C T I O N -- TC BioPharm/ PR Newswire EDINBURGH, Scotland, Dec. 30, 2024 In the news release, TCBP...

TCBP Trading Continues Unabated on Nasdaq Stock Exchange

TCBP Trading Continues Unabated on Nasdaq Stock Exchange PR Newswire EDINBURGH, Scotland, Jan. 6, 2025...

TCBP Provides Update on Acquisition Strategy and Current Targets

TCBP Provides Update on Acquisition Strategy and Current Targets PR Newswire EDINBURGH, Scotland, Dec. 31...

TCBP Issues 25% Stock Dividend

TCBP Issues 25% Stock Dividend PR Newswire EDINBURGH, Scotland, Dec. 30, 2024 EDINBURGH, Scotland, Dec. 30...

TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients

TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients PR Newswire EDINBURGH, Scotland...

TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend

TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend PR Newswire EDINBURGH...

TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy

TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

TC BioPharm Holdings PLC (TCBP)

Votre Hub pour des idées et discussions en direct en temps réel

TCBP Actualités

TCBP Announces H5N1 Proof of Concept Studies Intention

TCBP to Present at Sequire Investor Summit 2025

/C O R R E C T I O N -- TC BioPharm/

TCBP Trading Continues Unabated on Nasdaq Stock Exchange

TCBP Provides Update on Acquisition Strategy and Current Targets

TCBP Issues 25% Stock Dividend

TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients

TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend

TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy

TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial

TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant

TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements

TCBP Responds to False Social Media Claim

TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic

TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

TC BioPharm Holdings PLC (TCBP) Actualités

TC BioPharm Holdings PLC (TCBP)

Votre Hub pour des idées et discussions en direct en temps réel

TCBP Actualités

TCBP Announces H5N1 Proof of Concept Studies Intention

TCBP to Present at Sequire Investor Summit 2025

/C O R R E C T I O N -- TC BioPharm/

TCBP Trading Continues Unabated on Nasdaq Stock Exchange

TCBP Provides Update on Acquisition Strategy and Current Targets

TCBP Issues 25% Stock Dividend

TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients

TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend

TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy

TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial

TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant

TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements

TCBP Responds to False Social Media Claim

TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic

TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application